Molecular typing and characterization of TEM, SHV, CTX-M, and CMY-2 β-lactamases in Enterobacter cloacae strains isolated in patients and their hospital environment in the west of Algeria

Medecine et Maladies Infectieuses

Volumn 44, Issue 4, 2014, Pages 146-152

  Souna, D ^a   Amir, A S ^b   Bekhoucha, S N ^c   Berrazeg, M ^a   Drissi, M ^a  

^a UNIVERSITY OF TLEMCEN   (Algeria)

^b Service d'anesthésie réanimation du CHU Hassani Abdelkader Sidi   (Algeria)

^c CHU Oran   (Algeria)

Author keywords

Antibiotic resistance; Enterobacter cloacae; Extended spectrum lactamase

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 3; BETA LACTAMASE SHV; BETA LACTAMASE SHV 12; BETA LACTAMASE TEM 1; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG; BETA LACTAMASE; BETA-LACTAMASE CMY-2; BETA-LACTAMASE CTX-M-3; BETA-LACTAMASE CTX-M-5; BETA-LACTAMASE SHV-12; BETA-LACTAMASE TEM-1;

ALGERIA; ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM DETECTION; BACTERIUM ISOLATION; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROPORATION; ENTEROBACTER CLOACAE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE TRANSFER; GENETIC RESISTANCE; GENOTYPE; HUMAN; HUMAN CELL; MOLECULAR TYPING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; UNIVERSITY HOSPITAL; CLASSIFICATION; CLINICAL TRIAL; ENZYMOLOGY; HOSPITAL; ISOLATION AND PURIFICATION; METABOLISM; MULTICENTER STUDY;

ALGERIA; BETA-LACTAMASES; COHORT STUDIES; ENTEROBACTER CLOACAE; HOSPITALS; HUMANS; MOLECULAR TYPING; RETROSPECTIVE STUDIES;

EID: 84899967823     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2014.01.008     Document Type: Article

References (33)

1. Matsushima A., Takakura S., Fujihara N., Saito T., Ito Y., Iinuma Y., et al. High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection. Clin Microbiol Infect 2010, 16:1488-1493.
2. Hoffmann H., Sturenburg E., Heesemann J, Roggenkamp A. Prevalence of extended-spectrum β-lactamases in isolates of the Enterobacter cloacae complex from German hospitals. Clin Microbiol Infect 2006, 12:322-330.
3. Jeong S.H., Bae I.K., Lee J.H., Sohn S.G., Kang G.H., Jeon G.J., et al. Molecular characterization of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean Nationwide Survey. J Clin Microbiol 2004, 42(7):2902-2906.
4. Hanson N.D. AmpC β-lactamases: what do we need to know for the future?. J Antimicrob Chemother 2003, 52:2-4.
5. Mak J.K., Kim M.J., Pham J., Tapsall J., White P.A. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2009, 63:47-54.
6. Silva-Sanchez J., Ulises Garza-Ramos J., Reyna-Flores F., et al. Extended-spectrum β-lactamase-producing enterobacteriaceae causing nosocomial infections in Mexico. A retrospective and multicenter study. Arch Med Res 2011, 42:156-162.
7. CA-SFM. 2010. Comité de l'antibiogramme de la société française de microbiologie. Sur le lien: http://www.sfm.asso.fr/.
8. Ben Achour N., Choucheni C., Bouhawala N., Amor A., Belhadj O. Clinical strain of Proteus mirabilis able to produce a plasmid mediated ceftazidimase. Pathol Biol 2007, 42:127-130.
9. De Champs C. Perspective survey of β-lactamase produced ceftazidim. Agent Chemother 2002, 46(9):30-34.
10. Szabo' D., Bonomo R.A., Silveira F., William Pasculle A., Baxter C., Linden P.K., et al. SHV-type extended-spectrum (-lactamase production is associated with reduced cefepime susceptibility in Enterobacter cloacae). J Clin Microbiol 2005, 43(10):5058-5064.
11. Kaufmann M.E. Pulse-field gel electrophoresis. Methods Mol Med 1998, 15:17-31.
12. Tenover F.C., Arbeit R., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
13. Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 1984, 12:19-36.
14. Danel F., Hall M.C., Gur D., Livermore D. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) (-lactamase from Pseudomonas aeruginosa). Antimicrob Agents Chemother 1995, 39:1881-1884.
15. Touati A., Benallaoua S., Forte D., Madoux J., Brasme L., De Champs C. First report of CTX-M-15 CTX-M-3 β-lactamase among clinical isolates of Enterobacteriacae in Béjaia, Algeria. Int J Antimicrob Agents 2006, 27:397-402.
16. Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol 2010, 13:558-564.
17. Matsumoto Y., Inoue M. Characterisation of SFO-1, a plasmid-mediated inductible class A β-lactamase from Enterobacter cloacae. Antimicrob Agents Chemother 1999, 43:307-313.
18. Dorsey G., Borneo H., Sun S., et al. A heterogeneous outbreak of Enterobacter cloacae and Serratia marcescens infections in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000, 21:465-469.
19. Sergei B.V., Golemi D., Geryk B., Suvorov M., Knox J.R., Mobashery S., et al. Mutational replacement of Leu-293 in the class C Enterobactercloacae P99 (-lactamase confers increased MIC of cefepime). Antimicrob Agents Chemother 2002, 46(6):1966-1970.
20. Bauernfeind A., Grimm H., Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1990, 18:294-298.
21. Radice M., Power P., Di Conza J., Gutkind G. Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 2002, 46:602-604.
22. Tzouvelekis L.S., Tzelepi E., Tassios P.T., Legakis N.J. CTXM- type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000, 14:137-142.
23. Mamlouk K., Boutiba-Ben Bakour I., Gautie V., Vimont S., Picard B., et al. Emergence and outbreaks of CTX-M extended spectrum (-lactamase producing Echerichia coli and Klebsiella pneumoniae strains in a Tunisian hospital). J Clin Microbiol 2006, 44:4049-4059.
24. Livemore D.M., Canton R., Gniadkowski M.P., Rossolini G.M., Arlet G., Ayala J., et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007, 59:165-174.
25. Labdene H., Messai Y., Ammari H., Ramdani-Bouguessa N., Lounes S., Bakour R., et al. Dissemination of ESBL and Qnr determinants in Enterobactercloacae in Algeria. J Antimicrob Chemother 2008, 62:133-136.
26. Touati A., Brasme L., Benallaoua S., Gharout A., Madoux J., Champs C. First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals. Diagn Microbiol Infect Dis 2008, 60:287-290.
27. Meradi L., Djahoudi A., Abdi A., Bouchakour M., Perrier Gros Claude J.D., Timinouni M. Qnr and aac (6')-Ib-cr types quinolone resistance among Enterobacteriaceae isolated in Annaba, Algeria. Pathol Biol (Paris) 2011, 59:73-78.
28. Roh K.H., Uh Y., Kim J.S., Kim H.S., Shin D.H., Song W. First outbreak of multidrug- resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum β-lactamase and DHA-1-Type AmpC β-lactamase at a Korean Hospital Yonsei. Med J 2008, 49(1):53-57.
29. Pitout J.D.D., Moland E.S., Sanders C.C., Thomson K.S., Fitzsimmons S.R. β-lactamases and detection of β-lactam resistance in Enterobacter spp. Antimicrob Agents Chemother 1997, 41(1):35-39.
30. Kim J., Lim Y.M., Jeong Y.S., et Seol S.Y. Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum (-lactamases in Enterobacteriaceae clinical isolates in Korea). Antimicrob Agents Chemother 2005, 49:1572-1575.
31. Dutour C., Bonnet R., Marchandin H., Boyer M., Chanal C., Sirot D., et al. CTX-M-1, CTX-M-3, and CTX-M-14 β-lactamases from Enterobacteriaceae isolated in France. Antimicrob Agents Chemother 2002, 46:791-795.
32. Maurice B., Manoliu C., Laurans G., Castelain S., Canarelli B., Thomas D., et al. Molecular typing and characterization of extended-spectrum TEM, SHVand CTX-M β-lactamases in clinical isolates of Enterobacter cloacae. Res Microbiol 2008, 159:590-594.
33. Jeong S.H., Bae I.K., Lee J.H., Sohn S.G., Kang G.H., Jeon G.J., et al. Molecular characterization of extended-spectrum (-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean Nationwide Survey). J Clin Microbiol 2004, 42(7):2902-2906.